Savara Inc. and Mast Therapeutics Inc (NYSEMKT:MSTX) reported the expected exchange ratio computed under the January 6, 2017 merger deal. Upon closure of the merger deal, each due share of Savara common stock will be converted into the right to get 0.5860 of a share of MSTX after adjusting...
VentriPoint Diagnostics Ltd.(CVE:VPT) has submitted an application with Health Canada for nod of the extension of the VMS™ heart analysis system to include left atrium (LA), left ventricle (LV) and right atrium (RA) chambers of the heart. The system is already approved in Canada for the RV use. This...
Heat Biologics Inc (NASDAQ:HTBX) recently said that the survival results and top-line response of Phase 1b study evaluating lung cancer treatment with Bristol-Myers Squibb’s drug showed positive signs. The company reported HS-110/Nivolumab Combination for treating non-small cell lung cancer (NSCLC) in Austria at International Association for the Study of...
Shares of Rite Aid Corporation (NYSE:RAD) last traded at $3.00. (NYSE:RAD) performance year to date is -63.59%. The 200 day simple moving average is -52.19%. The 200 SMA is considered a major indicator by market analysts and traders for determining the long-term trend. The price in the market that...
Exelixis, Inc. (NASDAQ:EXEL) stock was trading in green in early trading hours on Thursday. The company in January reported that Genentech, Inc. has pulled its counterclaim against company in the underway JAMS arbitration pertaining alleged violations of the parties’ collaboration deal. Genentech had proclaimed a counterclaim for violation of...
Anthem Inc (NYSE:ANTM) is a leading health insurance company that has been competing at all levels with the leading health insurers of the country. But it seems it is not at all interested in the current high-power deals that are making a wave in the United States’ health insurance...
Aducanumab, a clinical treatment drug, primed to treat those with early symptoms of Alzheimer’s, recently went into Phase 1B clinical studies trial. Recently, the firm responsible for the manufacturing of the clinical treatment drugs, Biogen Inc. (NASDAQ:BIIB) released the data obtained from the Phase 1B trial. The data will be...
Galena Biopharma Inc (NASDAQ:GALE) recently announced the results of its meeting with Data Safety Monitoring Board (DSMB) for its clinical trials associated with NeuVax™ (nelipepimut-S) plus trastuzumab, meant for breast cancer patients. The clinical trial of the company’s latest treatment for breast cancer is being conducted in conjunction with...
Shares of Delcath Systems, Inc. (NASDAQ:DCTH) last traded at $0.10. (NASDAQ:DCTH) performance year to date is -89.24%. The 200 day simple moving average is -91.16%. The 200 SMA is considered a major indicator by market analysts and traders for determining the long-term trend. The price in the market that...
Here is an analysis at the scorecard of Delcath Systems Inc. (NASDAQ:DCTH) for the recent quarter and analyst projections for the coming periods. The firm generated sales of 743,000%, implying a jump of 0.5%% compared to a analogous quarter a year ago. To achieve the recorded sales of 743,000% for the...

Subscribe to our mailing list

* indicates required

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play